July 31, 2020
Nichi-Iko Pharmaceutical is not pursuing expanded shares with its generic takeover from Teva Takeda Pharma, but rather looking to enhance manufacturing efficiency and quality standards, President Yuichi Tamura said at a virtual press conference on July 30. “The deal is...read more